浮针疗法治疗老年躯体形式疼痛障碍的临床效果

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (550 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of floating needle therapy in the treatment of somatoform pain disorders in the elderly. Methods A total of 100 elderly patients with somatoform pain disorders admitted to the Seventh People’s Hospital of Hengshui City, Hebei Province from January to December 2020 were selected as the research objects. According to the random number table method, they were divided into the observation group and the control group, with 50 cases in each group. The control group was treated with Duloxetine and conventional acupuncture therapy, and the observation group was treated with Duloxetine and floating needle therapy. After 8 weeks of continuous treatment, the short-form McGill pain questionnaire (SF-MPQ) score, serum cortisol level, sleep quality (Pittsburgh sleep quality index [PSQI]) and quality of life were compared between the two groups before and after treatment. Results After treatment, the SF-MPQ scores in both groups were lower than those before treatment (P ＜ 0.05), and that in the observation group was lower than that in the control group (P ＜ 0.05). After treatment, the serum cortisol level of the observation group was lower than that before treatment, and that in the observation group was lower than that in the control group (P ＜ 0.05). After treatment, PSQI scores in both groups were lower than those before treatment, and that in the observation group was lower than that in the control group (P ＜ 0.05). After treatment, the scores of physiological function, psychological function, social relationship, and surrounding environment in both groups were higher than those before treatment, and those in the observation group were higher than those in the control group (P ＜ 0.05). Conclusion Floating needle therapy combined with Duloxetine in the treatment of elderly patients with somatoform pain disorders can relieve pain, reduce serum cortisol level, and improve the quality of sleep and the quality of life of patients. It is worthy of clinical application.

Key words： Floating needle therapy Duloxetine Somatoform pain disorders in the elderly Short-form McGill pain questionnaire Serum cortisol Sleep quality

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAI Xiangnan1 WANG Li1 WANG Xiaohuan1 MA Zhanping2▲

Cite this article:

ZHAI Xiangnan1 WANG Li1 WANG Xiaohuan1 MA Zhanping2▲. Clinical effect of floating needle therapy in the treatment of somatoform pain disorders in the elderly[J]. 中国医药导报, 2022, 19(18): 106-109.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I18/106

[1] 王晓环，马占平，栗建辉，等.文拉法辛联合度洛西汀治疗老年躯体形式疼痛障碍临床研究[J].中国药业，2021， 30（8）：26-28.
[2] 马占平，王晓环，翟向男，等.浮针疗法联合度洛西汀对躯体形式疼痛障碍老年患者疼痛程度、睡眠质量的影响[J].中国药业，2021，30（7）：72-74.
[3] Yoshino A，Okamoto Y，Jinnin R，et al. Role of coping with negative emotions in cognitive behavioral therapy for persistent somatoform pain disorder：Is it more important than pain catastrophizing [J]. Psychiatry Clin Neurosci，2019， 73（9）：560-565.
[4] Sun X，Pan X，Ni K，et al. Aberrant Thalamic-Centered Functional Connectivity in Patients with Persistent Somatoform Pain Disorder [J]. Neuropsychiatr Dis Treat，2020，16（1）：273-281.
[5] 符少剑，姚乾坤，卓东炳，等.度洛西汀肠溶胶囊联合艾司西酞普兰片治疗老年躯体形式障碍的临床研究[J].中国临床药理学杂志，2019，35（22）：2840-2843.
[6] 徐爽，董永生，孙淑红，等.调神止痛针法联合帕罗西汀治疗持续性躯体形式疼痛障碍的临床观察[J].广州中医药大学学报，2020，37（11）：2145-2151.
[7] 贾文，雒琳，何丽云，等.浮针疗法临床适宜病种的系统整理与分析[J].中国针灸，2019，39（1）：111-114.
[8] 李彤，孙红伟.浮针疗法结合延续性护理对脑卒中后肩手综合征的疗效观察[J].中国中医急症，2017，26（1）：164-166.
[9] 中华医学会精神科分会.中国精神障碍分类与诊断标准（CCMD-3）[M].3版.济南：山东科学技术出版社，2001：112-113.
[10] 王建俊，倪晶晶，李瑢，等.度洛西汀对持续性躯体形式疼痛障碍患者SF-36及TESS评分的影响[J].中国医师杂志，2021，23（1）：122-124.
[11] 路桃影，李艳，夏萍，等.匹兹堡睡眠质量指数的信度及效度分析[J].重庆医学，2014，43（3）：260-263.
[12] 郝元涛，方积乾.世界卫生组织生存质量测定量表中文版介绍及其使用说明[J].现代康复，2000（8）：1127-1129， 1145.
[13] 孙庆芳，王亚平.阿立哌唑联合度洛西汀治疗抑郁症的临床研究[J].现代药物与临床，2020，35（4）：712-716.
[14] 韩俊萍，田如新，樊碧发，等.度洛西汀和普瑞巴林治疗糖尿病性周围神经病理性疼痛疗效与安全性比较的Meta分析[J].中国疼痛医学杂志，2020，26（5）：357-361.
[15] 侯宁.低频重复经颅磁刺激联合度洛西汀治疗躯体化障碍的临床研究[J].心理月刊，2019，14（16）：10-11.
[16] 曲国欣，李洪潮，崔红旺，等.度洛西汀改善膝骨性关节炎疼痛症状有效性和安全性的Meta分析[J].中国药房，2020，31（11）：1372-1376.
[17] 姜默琳，卢伟.躯体症状障碍的治疗研究进展[J].医学综述，2018，24（20）：4039-4043.
[18] 孙晓伟，潘婷婷，刘婷婷，等.浮针疗法治疗肩周炎的理论及临床研究进展[J].针灸临床杂志，2020，36（4）：90-93.
[19] 厚晓昀，徐世红，戴智勇，等.浮针疗法在骨质疏松性胸椎压缩骨折术后肋间痛治疗中的应用价值[J].针刺研究，2021，46（4）：326-329，350.
[20] 于楠楠，马琳，毕海洋，等.浮针治疗帕金森病伴发四肢疼痛临床研究[J].针灸临床杂志，2020，36（1）：37-40.
[21] 敬娜，孙健，莫宗权，等.从患肌角度探讨浮针治疗股骨头坏死的作用机制[J].中医药导报，2020，26（8）：39-40，48.
[22] 李剑峰，唐福宇，梁冬波.浮针治疗腰椎后路内固定术后下腰痛的效果[J].广东医学，2019，40（14）：2071-2074.
[23] 范曼琪，孙健，许能贵，等.浮针治疗肩周炎的临床思维及作用机制[J].世界中医药，2021，16（5）：835-839.
[24] 李新伟，杜嘉，谭克平，等.浮针疗法配合肌肉能量技术治疗颈肩肌筋膜疼痛综合征疗效观察[J].中华中医药杂志，2017，32（2）：875-877.
[25] 邓玮瑜，曾胜田，庄纯.度洛西汀联合加巴喷丁治疗老年患者躯体形式疼痛障碍的效果[J].中国老年学杂志，2018，38（11）：2662-2664.
[26] Jia Y，Liu L，Sheng C，et al. Increased Serum Levels of Cortisol and Inflammatory Cytokines in People With Depression [J]. J Nerv Ment Dis，2019，207（4）：271-276.